Batches of Itraconazole recalled by MHRA
Batches of Itraconazole 10mg/ml oral solution have been recalled by the Medicines and Health products Regulatory Agency.
The recall of the drug, manufactured by Thame Laboratories, was made after an issue with the child-resistant cap was discovered, prompting the MHRA to urge pharmacists and other health professionals to stop supplying batches L465 and L475 immediately.
“The Marketing Authorisation Holder has received a number of complaints regarding the child-resistant caps which were difficult to open, and their investigation has identified an issue with the bottle capping process during the manufacture of the product,” the PSNC said.
This module busts the myths surrounding diarrhoea treatments and explores the products available OTC so you can recommend the right treatment.
Discover the link between dry eye and blepharitis and learn how to help customers effectively manage these conditions.
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Modafinil carries significant risk of birth defects, warns MHRA
A drug used to treat sleep disorders carries a risk of birth defects when taken in pregnancy.
1 Min Article
NHS flu vaccination advertising starts early October
The campaign will consist of TV, radio and digital advertising supported by search and partnership activity.
1 Min Article
1k jabs per week rule to stay ‘until supply improves’
The Government won’t relax rules preventing smaller pharmacies from taking part in the Covid-19 vaccination programme until “supply allows".
2 Min Article